Medical News

RSS

ChemoCentryx reports one-year study results of Traficet-EN in Crohn's disease patients

ChemoCentryx, Inc., today announced that it reported one-year results from the Company's PROTECT-1 Study (the Prospective Randomized Oral Therapy Evaluation in Crohn's disease Trial) of Traficet-EN™ (CCX282-B) in patients with moderate-to-severe Crohn's disease. Traficet-EN, an orally bioavailable CCR9-specific chemokine receptor antagonist showed clinical efficacy in a 12-week Induction period, as well as a 36-week Maintenance period.

28 Oct 2010

New GlideScope Direct intubation trainer to facilitate instruction for classic direct laryngoscopy

Verathon Inc. is pleased to introduce the GlideScope Direct intubation trainer, designed to facilitate instruction of classic direct laryngoscopy.

28 Oct 2010

Polio vaccination campaign targeting 72M children in 15 African countries announced; Ugandan health authorities declare polio outbreak

The WHO on Tuesday announced a mass polio immunization campaign in 15 African countries targeting a total of 72 million children, Agence France-Presse reports. "Polio has spread again in recent years with cases imported from some of the four endemic nations in Asia and Africa, mainly Nigeria, in a setback to global attempts to eradicate the crippling and sometimes lethal disease," the news service writes (10/26).

28 Oct 2010

Report notes potential for African agriculture, European partnerships

A new report highlights concerns about donors, especially from Europe, following through on funding pledges for the G8's $22 billion global food security fund, Business Daily reports.

28 Oct 2010

EpiCept, FDA reach agreement on regulatory path forward for Ceplene

EpiCept Corporation today announced that it has reached an agreement on all outstanding issues with the U.S. Food and Drug Administration (FDA) on a regulatory path forward for Ceplene® (histamine dihydrochloride), the Company's lead product for the remission maintenance and prevention of relapse of patients with acute myeloid leukemia (AML) in first complete remission. Ceplene® is approved in the European Union for this indication and is marketed there by Meda AB.

28 Oct 2010

Elevated amounts of SP2 protein turn stem cells into cancerous tumors: Research

Researchers at North Carolina State University have found that the overproduction of a key protein in stem cells causes those stem cells to form cancerous tumors. Their work may lead to new treatments for a variety of cancers.

28 Oct 2010

B. Braun initiates voluntary recall of heparin injection products

B. Braun Medical Inc. was recently notified by its supplier, Scientific Protein Laboratories LLC (SPL), of a nationwide recall of a lot of Heparin Sodium USP Active Pharmaceutical Ingredient (API) sold to B. Braun because additional testing of retained crude heparin samples used by SPL to manufacture this single API lot indicated a trace amount of oversulfated chondroitin sulfate (OSCS) contaminant.

From B. Braun Melsungen AG 28 Oct 2010

Nymox updates NX-1207 Phase 3 pivotal trials for benign prostatic hyperplasia

Nymox Pharmaceutical Corporation provided an update today on the Company's Phase 3 pivotal trials for NX-1207, Nymox's investigational drug for benign prostatic hyperplasia (BPH).

28 Oct 2010

A look at the secretive AMA panel behind Medicare's payment rates

A group of 29 physicians, convened by the American Medical Associations and "mostly selected" by specialty trade groups, have the task of recommending how to divide Medicare money into payments for each service, procedure and treatment the program covers, The Wall Street Journal reports.

28 Oct 2010

Health Canada approves PRADAX anticoagulant for stroke prevention in AF patients

Boehringer Ingelheim Ltd. today announces that Health Canada has granted approval of PRADAX (dabigatran etexilate), an oral anticoagulant for the prevention of stroke and systemic embolism in adults with atrial fibrillation in whom anticoagulation is appropriate. PRADAX is the first innovative drug approved in Canada in more than two decades to reduce the risk of stroke in Canadians with atrial fibrillation.

28 Oct 2010

New oral drug shrinks IMT sarcoma driven by abnormally activated protein

A new oral drug caused dramatic shrinkage of a patient's rare, aggressive form of soft-tissue cancer that was driven by an abnormally activated protein, physician-scientists from Dana-Farber Cancer Institute report in the Oct. 28 issue of the New England Journal of Medicine.

28 Oct 2010

More effective therapeutic exercises underutilized in treatment of chronic neck pain

Duke University and University of North Carolina (UNC) researchers report in the November issue of Arthritis Care & Research that narcotics and diagnostic testing are overused in treating chronic neck pain. Their findings indicate clinicians may overlook more effective treatments for neck pain, such as therapeutic exercise. According to reviews cited in the study, evidence to support the effectiveness of therapeutic exercise in treating chronic neck pain is good, yet only 53% of subjects were prescribed such exercise.

28 Oct 2010

Sec. of State Clinton commits $44M toward new initiatives to empower women

Marking the 10th anniversary of U.N. Security Council Resolution 1325 the first to recognize the importance of women's 'full involvement' in efforts to maintain and promote peace and security Secretary of State Hillary Clinton on Tuesday together with U.N. Secretary-General Ban Ki-moon and diplomats called for increased action to end sexual violence in war and increase women's involvement in peace-building efforts, the Associated Press/Forbes reports.

28 Oct 2010

New findings suggest way to treat lung diseases

A new study of an exotic, infectious virus that has caused three recent outbreaks in the United States reveals clues to how the virus might damage lungs during infection. The findings also suggest possible new ways to treat lung diseases in humans.

28 Oct 2010

CutisPharma receives U.S patent for suppository compounding

CutisPharma, Inc. today announced that it has received approval from the United States Patent and Trademark Office for its patent (US 7,815,929) regarding a method for the preparation, storage and dispensing of compounded suppositories.

28 Oct 2010

Mass. hospitals turn away mentally ill kids, Anthem braces for rate hearings, other state news

The Boston Globe reports that children with mental illnesses are "increasingly being turned away from some Massachusetts hospitals' psychiatric wards, a problem the hospital industry acknowledges and blames on insufficient insurance payments to cover treatment of such sick children. … Dr. JudyAnn Bigby, the state's health and human services secretary, said yesterday that hospitals licensed to treat mentally ill children must provide that care if they have sufficient staffing and beds, regardless of the reimbursement rates" (Lazar, 10/27).

28 Oct 2010

Intuit Health patient portal solutions selected by AMS for physician practices

American Medical Software (AMS) has selected Intuit Inc's Intuit Health to provide its physician practices with a patient portal solution. Through this agreement, millions of patients of AMS clients will now be able to easily communicate with their provider and complete key tasks online.

28 Oct 2010

Omnyx initiates research testing of digital pathology platform

GE Healthcare and UPMC announced today that their imaging joint venture, Omnyx, is initiating clinical research testing of a breakthrough digital pathology platform that is expected to help transform the 125-year-old practice of pathologists using glass slides.

28 Oct 2010

BDSI to initiate BEMA Buprenorphine Phase 3 program following positive End-of-Phase 2 meeting with FDA

BioDelivery Sciences International, Inc. today announced a positive End-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA) which took place on September 14, 2010. At that meeting, agreement was reached on the BEMA Buprenorphine development plan for the treatment of chronic pain.

28 Oct 2010

Reuters examines development progress of microbicide gel to prevent HIV

Reuters reports that the developers of a vaginal microbicide gel containing the antiretroviral tenofovir, which has been found to reduce "HIV infections in women by 39 percent," said the FDA last week granted fast-track approval designation to the gel.

28 Oct 2010

Medical News

ChemoCentryx reports one-year study results of Traficet-EN in Crohn's disease patients

New GlideScope Direct intubation trainer to facilitate instruction for classic direct laryngoscopy

Polio vaccination campaign targeting 72M children in 15 African countries announced; Ugandan health authorities declare polio outbreak

Report notes potential for African agriculture, European partnerships

EpiCept, FDA reach agreement on regulatory path forward for Ceplene

Elevated amounts of SP2 protein turn stem cells into cancerous tumors: Research

B. Braun initiates voluntary recall of heparin injection products

Nymox updates NX-1207 Phase 3 pivotal trials for benign prostatic hyperplasia

A look at the secretive AMA panel behind Medicare's payment rates

Health Canada approves PRADAX anticoagulant for stroke prevention in AF patients

New oral drug shrinks IMT sarcoma driven by abnormally activated protein

More effective therapeutic exercises underutilized in treatment of chronic neck pain

Sec. of State Clinton commits $44M toward new initiatives to empower women

New findings suggest way to treat lung diseases

CutisPharma receives U.S patent for suppository compounding

Mass. hospitals turn away mentally ill kids, Anthem braces for rate hearings, other state news

Intuit Health patient portal solutions selected by AMS for physician practices

Omnyx initiates research testing of digital pathology platform

BDSI to initiate BEMA Buprenorphine Phase 3 program following positive End-of-Phase 2 meeting with FDA

Reuters examines development progress of microbicide gel to prevent HIV

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News